If You Can't Find Dexmethylphenidate XR, You're Not Alone

You've called pharmacy after pharmacy, and nobody has your medication in stock. If you take Dexmethylphenidate XR (brand name Focalin XR) for ADHD, you've likely experienced the frustration of not being able to fill your prescription. The shortage has been dragging on since 2022, and in 2026, many patients are still struggling to find it.

This article explains what Dexmethylphenidate XR is, why it's been so hard to find, and — most importantly — what you can do about it right now.

What Is Dexmethylphenidate XR?

Dexmethylphenidate XR is an extended-release stimulant medication prescribed to treat Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 and older and adults. It's the active part (the "d" isomer) of Methylphenidate, the same ingredient in Ritalin and Concerta — but refined so you get more effect with a lower dose.

The "XR" stands for extended-release. You take it once daily in the morning, and it works for about 12 hours. It comes in capsule form in strengths from 5 mg to 40 mg. You can swallow the capsule whole or open it and sprinkle the beads on applesauce if swallowing pills is difficult.

Dexmethylphenidate XR is a Schedule II controlled substance, which means it has recognized medical use but also carries a risk of abuse and dependence. This classification plays a big role in why it's hard to find — more on that below.

Why Is Dexmethylphenidate XR So Hard to Find?

There's no single reason. The shortage is caused by several overlapping problems:

1. DEA Production Quotas Limit How Much Can Be Made

Because Dexmethylphenidate is a Schedule II controlled substance, the Drug Enforcement Administration (DEA) sets annual limits — called production quotas — on how much manufacturers can produce. These quotas are meant to prevent diversion and abuse, but they also cap the supply. When demand rises faster than quotas are adjusted, shortages happen.

In 2024, the DEA transitioned to a new semi-annual quota system for non-injectable stimulants, but the changeover itself caused delays. Manufacturers didn't receive timely quota allocations, which disrupted production schedules that continued into 2025 and 2026.

2. Manufacturer Delays and Back Orders

Multiple generic manufacturers have had production problems. According to the ASHP (American Society of Health-System Pharmacists), Par Pharmaceutical has had several strengths of generic Dexmethylphenidate XR on back order with no estimated release date. Sandoz, which makes brand-name Focalin XR, has also experienced intermittent supply issues.

When one manufacturer falls behind, the remaining suppliers can't always pick up the slack — especially under DEA quota constraints.

3. Rising Demand for ADHD Medications

ADHD diagnoses have increased significantly in recent years, particularly among adults. The expansion of telehealth during and after the COVID-19 pandemic made it easier for people to get evaluated and receive prescriptions. More prescriptions being written means more demand for a supply that was already limited.

4. Pharmacy-Level Distribution Challenges

Even when a manufacturer has stock, it doesn't always reach every pharmacy. Large chain pharmacies and distributors may receive allocations first, while smaller or independent pharmacies get less. Some pharmacies also limit how much controlled substance inventory they carry, making it harder to find your specific dose on the shelf.

What You Can Do Right Now

The shortage is frustrating, but you have options:

• Use Medfinder to check real-time availability of Dexmethylphenidate XR at pharmacies near you. It's the fastest way to find which pharmacies actually have your medication in stock.
• Call independent pharmacies. They often have more flexibility with their inventory and may be able to order your medication directly from a wholesaler.
• Ask your doctor about alternatives. If your specific dose or formulation is unavailable, your prescriber may be able to switch you to a comparable medication like Methylphenidate ER (Concerta), Adderall XR, or Vyvanse.
• Don't wait until you're out. Start looking for refills at least 7-10 days before your current supply runs out. This gives you time to check multiple pharmacies.
• Talk to your pharmacist. They may know when their next shipment is expected or can put you on a waitlist.

For a step-by-step guide, see our article on how to find Dexmethylphenidate XR in stock near you.

Final Thoughts

The Dexmethylphenidate XR shortage is a real problem with real consequences for people who depend on this medication to manage their ADHD. DEA quotas, manufacturing delays, and surging demand have created a perfect storm that's left many patients scrambling.

But you're not powerless. Tools like Medfinder can help you locate your medication faster, and your healthcare provider can help you explore alternatives if needed. The situation is improving slowly as the DEA adjusts production quotas, but in the meantime, being proactive is your best strategy.

If you're also concerned about cost, check out our guide on how to save money on Dexmethylphenidate XR.